Extracorporeal membrane oxygenation vs cardiopulmonary bypass in lung transplantation: an updated meta-analysis
- 21 December 2024
- journal article
- review article
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 73 (3) , 137-146
Abstract
Aim This meta-analysis aimed to compare the outcomes of extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass (CPB) in lung transplantation. Methods We searched PubMed, Embase, and Cochrane databases for studies comparing ECMO to CPB in lung transplantation. Odds ratios (ORs) for binary endpoints and mean differences (MDs) for continuous outcomes were calculated with 95% confidence intervals (CIs). DerSimonian and Laird random-effects model was applied for all endpoints. I2 statistics was used to assess heterogeneity. Results Fourteen studies with a total of 1797 patients were included. ECMO was associated with significant reductions in hepatic dysfunction (OR 0.47, 95% CI 0.25–0.90), hemodialysis (OR 0.62, 95% CI 0.43–0.88), severe graft rejection (OR 0.43, 95% CI 0.23–0.78), one-year mortality (OR 0.70; 95% CI 0.51 to 0.98; p = 0.04; I2 = 13%) and tracheostomy rates (OR 0.62, 95% CI 0.46–0.86). Additionally, ECMO reduced the length of hospital stay (MD − 5.69 days, 95% CI − 9.31 to − 2.08) and ICU stay (MD − 6.02 days, 95% CI − 8.32 to − 3.71). However, ECMO was associated with longer total ischemic time (MD 61.07 min, 95% CI 3.51 to 118.62). No significant differences were observed for stroke, thromboembolic events, atrial fibrillation, or 30-day and 3-year mortality. Conclusions ECMO offers perioperative advantages in lung transplantation, reducing postoperative complications, one-year mortality, and recovery time compared to CPB. However, the longer total ischemic time with ECMO warrants further investigation into its long-term outcomes. Trial registry International Prospective Register of Systematic Reviews; N°: CRD42024604049; URL: https://www.crd.york.ac.uk/prospero/.Keywords
This publication has 67 references indexed in Scilit:
- Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial)American Heart Journal, 2024
- Effect of preoperative pulmonary hemodynamic and cardiopulmonary bypass on lung function in children with congenital heart diseaseEuropean Journal of Pediatrics, 2023
- Intraoperative Support for Primary Bilateral Lung Transplantation: A Propensity-Matched AnalysisThe Annals of Thoracic Surgery, 2022
- Intraoperative Extracorporeal Circulatory Support in Lung Transplantation for Pulmonary FibrosisThe Annals of Thoracic Surgery, 2021
- Perioperative circulatory support for lung transplantationGeneral Thoracic and Cardiovascular Surgery, 2021
- Venoarterial-Extracorporeal Membrane Oxygenation Without Routine Systemic Anticoagulation Decreases Adverse EventsThe Annals of Thoracic Surgery, 2020
- Acute Rejection and Antibody-Mediated Rejection in Lung TransplantationClinics in Chest Medicine, 2017
- Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysisGeneral Thoracic and Cardiovascular Surgery, 2017
- Outcomes of Intraoperative Venoarterial Extracorporeal Membrane Oxygenation Versus Cardiopulmonary Bypass During Lung TransplantationThe Annals of Thoracic Surgery, 2014
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986